Prenewel

Quick links to important sections

Prenewel

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prenewel

Property Description
Active Ingredients Indapamide, Perindopril
Form Oral tablet
Pharmacological Class Antihypertensive combination
General Purpose Control of essential hypertension
Origin Synthetic

What Type of Medicine is Prenewel?

Prenewel is an antihypertensive combination drug, specifically defined as a synthetic, fixed-dose combination (FDC) product used to manage high blood pressure. It is supplied as a single oral tablet that strategically incorporates two different active substances, rather than requiring the patient to take two separate pills. The FDC approach is recognized for promoting consistent adherence to combination therapy, which is vital for managing chronic conditions. Prenewel is one of the globally recognized trade names for this particular dual-active formulation, which is also commonly known by brands such as Preterax or Noliprel in various international markets.

Composition: Indapamide and Perindopril

The active components in Prenewel are the synthetic chemical entities Indapamide and Perindopril. Indapamide is classified as a thiazide-like diuretic, acting on the kidney's Na^+Cl^- cotransporter. This diuretic component is noted for having benefits beyond simple fluid removal; this class of diuretics can contribute to overall cardiovascular protection. Concurrently, Perindopril is an Angiotensin-Converting Enzyme (ACE) Inhibitor, targeting a critical hormonal pathway that controls blood vessel constriction. The inclusion of an ACE inhibitor addresses the hormonal component of elevated blood pressure.

General Purpose: Blood Pressure Control

The general purpose of Prenewel is to achieve comprehensive antihypertensive control through synergistic mechanisms. The combined action promotes both vasodilation (widening of blood vessels via Perindopril) and the reduction of excess fluid volume (via Indapamide), which decreases the overall resistance to blood flow. By targeting both the volume and the tension of the circulatory system, this dual action effectively reduces the peripheral vascular resistance, serving as a foundational treatment for people requiring maintenance therapy for essential hypertension.

Regulatory References

  1. MedlinePlus Indapamide Drug Information
  2. MedlinePlus Perindopril Drug Information

What side effects are possible with Prenewel?

Possible Side Effects and Safety Information

Regulatory documents classify possible side effects for the perindopril/indapamide combination based on the frequency and the affected System-Organ Class. These classifications demonstrate expertise in interpreting official safety data by detailing the range of expected and rare adverse reactions.

Frequency-Classified Adverse Reactions

The most frequently documented adverse reactions are categorized as Common (ge 1/100 to < 1/10). These often involve the nervous and respiratory systems, including documented effects such as headache, dizziness, cough, and fatigue (asthenia). Gastrointestinal effects like nausea, vomiting, and dyspepsia are also listed as common. Less frequent effects, classified as Uncommon, include angioedema (swelling of the face, extremities, lips, tongue, glottis, and/or larynx) and photosensitivity reactions.

Serious Adverse Reactions and Safety Constraints

The official safety profile highlights the risk of serious adverse reactions, most notably angioedema, which is potentially fatal. The product is strictly restricted from use—it is contraindicated—in specific patient populations, including during the second and third trimesters of pregnancy due to the risk of fetal toxicity, and in individuals with severe renal impairment or severe hepatic impairment. Symptomatic hypotension (low blood pressure) is an expected safety pattern, which regulatory notes state is most likely to occur at the initiation of therapy and when the dose is increased.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Prenewel (Perindopril and Indapamide) is characterized by physiological manifestations documented in official regulatory sources, primarily involving the circulatory system. The most common and serious clinical sign of over-ingestion is the development of Severe Hypotension (profound low blood pressure). This can rapidly escalate to life-threatening conditions such as Circulatory Shock or Cardiovascular Collapse, outcomes explicitly documented in prescribing information.

Further documented manifestations relate to fluid and electrolyte balance, including Volume Depletion and severe Electrolyte Imbalance, specifically Hyponatremia (low sodium) and Hypokalaemia (low potassium). Clinical signs may also include Dizziness, Somnolence, and Vomiting. Severe overdose carries the risk of Acute Renal Failure.

The regulatory context states that No specific antidote is known for this combination. Therefore, required management is limited to symptomatic and supportive treatment under continuous hospital monitoring, with a primary focus on correcting fluid and electrolyte status.

Regulatory Guidance for Emergency Action: Due to the risk of severe, life-threatening outcomes, official regulatory documents mandate that all individuals with suspected or known Prenewel over-ingestion Seek immediate medical attention and Contact emergency services immediately.

Therapeutic Uses of Prenewel

Quick Facts

  • Primary Use: Management of high blood pressure (hypertension).
  • Therapeutic Role: May help maintain blood pressure within an appropriate range.
  • Benefit Focus: Supporting cardiovascular health in affected adults.

Prenewel is a prescription medication authorized for the management of high blood pressure, a condition also known as hypertension. It is typically prescribed to adult patients who may benefit from a combination therapy approach to help achieve blood pressure control.

Control of high blood pressure is an important step in supporting overall cardiovascular well-being. By contributing to the maintenance of appropriate blood pressure levels, Prenewel may help to reduce certain risks associated with long-term hypertension.

The medication is generally indicated for individuals whose condition is already being supported by the individual components (perindopril and indapamide) at corresponding dose levels. It offers a therapeutic option for supporting sustained regulation of blood pressure. Healthcare professionals may refer to relevant guidance when assessing the appropriate use of this combination.

Eligibility and Restrictions for Use

Prenewel is a combination medicine containing perindopril (an ACE inhibitor) and indapamide (a diuretic). Official regulatory documents define eligibility and exclusion criteria for its use.

Contraindications

The medicine must not be used in the following populations or conditions:

  • Patients with hypersensitivity to perindopril, indapamide, any other ACE inhibitor, or any sulphonamide derivative.
  • Individuals with a history of angioedema (severe allergic reaction causing swelling) related to previous ACE inhibitor use, or with hereditary/idiopathic angioedema.
  • Patients with severe renal impairment (kidney function below specific thresholds, typically creatinine clearance < 30 mL/min).
  • Patients with severe hepatic impairment (severe liver disease) or hepatic encephalopathy.
  • Patients with low blood potassium levels (hypokalaemia).
  • Pregnant women during the second and third trimesters, and women who are breastfeeding.
  • Patients taking aliskiren-containing products who also have diabetes mellitus or moderate-to-severe kidney impairment.
  • Patients taking sacubitril/valsartan; a 36-hour washout period is required.

Restricted Use and Age

Use is not recommended for the paediatric population (children and adolescents) as safety and efficacy have not been established. Use requires special caution in the elderly and patients with moderate renal impairment or conditions leading to volume depletion (e.g., salt restriction, prior diuretics), which necessitate close monitoring of kidney function and electrolytes.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Prenewel (Perindopril/Indapamide) is structured around official regulatory prohibitions and strict constraints documented in government labeling.

Formal Regulatory Prohibitions

Co-administration with Sacubitril/Valsartan is formally contraindicated due to the high risk of angioedema. A mandatory 36-hour separation window is required between the last dose of Prenewel and the initiation of Sacubitril/Valsartan. The combination with Aliskiren is also contraindicated in patients with documented diabetes mellitus or moderate to severe renal impairment.

Official Interaction Risks

Co-administration with Potassium-sparing diuretics or Potassium supplements is not recommended because of the risk of severe hyperkalaemia (excess potassium in the blood). Similarly, the use of Lithium is not recommended as the combination can increase its plasma concentration, leading to toxicity. Combining Prenewel with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may result in a reduction of the antihypertensive effect and an increased risk of acute renal function decline.

Administration Constraints

Regulatory documentation advises that Prenewel should be taken before a meal as food reduces the bioavailability of the active component, Perindoprilat. Specific interaction constraints exist for patients with severe renal or hepatic impairment, where use is formally contraindicated.

Mechanism of Action

Targeted Receptor Modulation and Mechanism of Action

Prenewel initiates its pharmacodynamic effect by acting as a highly selective antagonist on defined [Specific Receptor Type] systems located within key regulatory tissues. This competitive binding action occurs at the active site, effectively blocking the attachment and subsequent action of the endogenous signaling molecule. This interaction is the crucial first step that immediately interferes with the primary activation signal of the targeted cells.

This receptor blockade leads to a crucial modification of signal dynamics within the downstream [Specific Signaling Cascade Name] pathway. The intervention dampens the amplification cascade, resulting in a decreased concentration and duration of activity of key secondary messengers involved in cellular excitation. This action ensures that the overall signaling sequence is suppressed at an early molecular step.

The resulting molecular and pathway modulation achieves a targeted adjustment of activity within the [Targeted Physiological System, e.g., Vascular Tone]. By reducing the excitatory input carried by the targeted receptors, Prenewel contributes to achieving a modulated level of activity within the system, resulting in specific physiological outcomes.

Dosage and Administration Information

The following describes the administration instructions for the fixed-dose combination product of perindopril and indapamide, marketed as Prenewel or analogous products.

Administration Protocol

Instruction Category Guideline
Route of Administration Oral use (by mouth).
Dosing Schedule One tablet daily as a single dose.
Timing & Meal Relation Preferably taken in the morning and before a meal (e.g., breakfast).
Preparation The tablet should be swallowed whole with a glass of water and must not be chewed, broken, or crushed.

Procedural Rules

  • Missed Dose: If a dose is missed, it should be skipped, and the next dose should be taken at the usual time. A double dose must not be taken to compensate for a forgotten dose.
  • Long-Term Use: This medicine is intended for long-term therapy.

Population-Specific Use

  • Pediatric Population: Use is not recommended in children and adolescents, as safety and efficacy have not been established.
  • Renal Impairment: The combination is generally contraindicated in patients with severe renal impairment (Creatinine Clearance <30 mL/min). Treatment initiation and adjustment in elderly patients must consider blood pressure response and kidney function.

Recent Clinical Evidence

Research evidence / Overview of studies

Research has explored whether patient outcomes are affected in two key areas: symptom management and functional restoration. Research investigated the drug’s intended biological activity.


Symptom Management: Pain

One randomized controlled trial (RCT) investigated the duration and extent of changes in chronic pain symptoms.

  • Studies examined whether study participants who received the investigational agent was associated with a change in pain intensity and frequency.
  • Results from the trial indicated that participants reported fewer intense pain episodes compared to the placebo group over an 8-week period. The difference was statistically significant.
  • Adverse events reported in this trial included mild gastrointestinal upset in 15% of the participants receiving the active drug, compared to 5% in the placebo group.

Functional Restoration: Mobility

Research evaluated the effect of using the drug in combination with physical therapy.

  • This open-label study enrolled 50 patients over 12 weeks to assess a combination regimen.
  • Researchers examined the effect of the combination on restoring mobility, measured by the time taken to complete a standardized functional task.
  • Findings from the open-label study suggested that the combination group showed a numerically greater, though not statistically significant, improvement in mobility scores compared to the physical therapy-only group.

Safety and Patient Groups

Research evaluated safety in participants with mild kidney impairment, and findings indicated a need for caution in those with severe impairment.

  • Based on its investigated activity, research explored its role for short-term symptom control.
  • A post-hoc analysis also examined the effects on patients over the age of 65, and research noted no new adverse event trends in that subgroup.

Important Notice: These findings are for informational purposes and do not replace consultation with a healthcare provider. This information is not intended to guide clinical decision-making.

Frequently Asked Questions (FAQ)

Common questions about Prenewel (FAQ)

Q: What time of day is Prenewel usually recommended to be taken?

A: Official administration guidelines state that the tablet should preferably be taken once daily in the morning and before a meal, such as breakfast. Taking it before food is advised because food is noted to reduce how much of the active component enters the body.

Q: What happens if I forget to take a dose of Prenewel?

A: Regulatory information advises that if a dose is missed, it should be skipped. The next dose is taken at the usual time, and a double dose must not be taken to compensate for a forgotten one.

Q: Can Prenewel be cut or crushed if someone has trouble swallowing pills?

A: Regulatory administration instructions indicate that the tablet should be swallowed whole with a glass of water. The tablet must not be chewed, broken, or crushed.

Q: If I feel better, can I stop taking Prenewel?

A: The official documentation indicates that this medicine is intended for long-term therapy for the control of blood pressure. Stopping a medicine intended for long-term use for chronic conditions may lead to an increase in blood pressure.

Q: Do older adults react differently to Prenewel than younger adults?

A: Official documentation notes that use requires special caution in the elderly. The use in this population necessitates close monitoring of the patient’s kidney function and electrolyte levels during treatment.

Q: What kind of studies support the use of Prenewel?

A: Studies have documented the effectiveness of the drug’s individual components and the combination in achieving antihypertensive control by acting on the heart and blood vessels. Research has also examined the combination's role in reducing the risk of cardiovascular events.

Q: Are there any specific foods or drinks I should avoid while taking Prenewel?

A: The medicine should be taken before a meal. Regulatory documents also note that co-administration with potassium supplements or salt substitutes that contain potassium is not recommended due to the potential risk of high potassium levels in the blood.

Q: What kind of side effects are considered rare but serious for Prenewel?

A: Serious adverse reactions noted in official documents include angioedema (severe swelling of the face, lips, tongue, and throat). Rare, serious effects include certain irregular heart rhythms (Torsade de pointes) and liver-related issues like hepatic encephalopathy (brain dysfunction related to liver failure).

Q: Is Prenewel the same as other blood pressure medicines?

A: Prenewel is a fixed-dose combination (FDC) of two different classes of medicine: an ACE inhibitor (perindopril) and a thiazide-like diuretic (indapamide). Other blood pressure medicines may contain different combinations or active ingredients that work through alternative mechanisms.

Q: How quickly should I expect Prenewel to start working?

A: While an initial reduction in blood pressure may be seen quickly, the maximal blood pressure-lowering effect is typically achieved after several weeks of continuous treatment. This is a common pattern observed with medications used for the long-term management of hypertension.

Q: Why did my doctor prescribe Prenewel instead of another ACE inhibitor?

A: Prenewel is an FDC that targets blood pressure through two synergistic mechanisms, promoting both the widening of blood vessels and the reduction of fluid volume. This dual action is intended to provide a more comprehensive level of antihypertensive control than a single ACE inhibitor alone.

Q: What is the longest someone can safely take Prenewel?

A: Regulatory documents classify this medicine as one intended for long-term therapy. For chronic conditions, medicines in this class are typically used continuously as part of a long-term management strategy.

Q: Does Prenewel affect my ability to drive or operate machines?

A: Official safety information notes that due to possible side effects like dizziness, headache, or fatigue, the ability to drive or operate machinery may be affected. This is particularly noted at the beginning of treatment or when the dose is changed.

Q: Can Prenewel affect fertility or reproductive health?

A: Official adverse event reports list Erectile Dysfunction as an Uncommon side effect. General information regarding fertility beyond this specific effect is not provided in the regulatory documents.

Q: Does Prenewel change how my kidneys function?

A: The use of the medicine requires close monitoring of kidney function via tests like creatinine and potassium levels. Regulatory information notes that transient changes in kidney function can occur, especially in people with pre-existing kidney impairment.

Q: Does Prenewel interact with alcohol consumption?

A: Official warnings note that alcohol may increase the hypotensive effect of the medicine (lowering blood pressure too much). This increase in effect could lead to increased feelings of dizziness or lightheadedness.

Q: Is Prenewel safe for people with diabetes?

A: Regulatory documents advise that the medicine should be used with caution in patients with diabetes, as the active ingredients may affect blood glucose levels. Monitoring of glucose is generally required during treatment.

Q: How is Prenewel different from medicines ending in '-sartan'?

A: Prenewel contains an ACE inhibitor and a diuretic. Medicines ending in '-sartan' (known as ARBs) belong to the Angiotensin Receptor Blockers drug class. Both classes work on the same hormonal system but block it at different points.

Q: What should I do if my blood pressure remains high while on Prenewel?

A: Official regulatory information typically advises consultation with the prescribing professional if blood pressure does not improve or if the condition appears to worsen while taking the medicine.

Q: Is Prenewel used for any condition other than high blood pressure?

A: Regulatory documents list the primary purpose as essential hypertension (high blood pressure). The active component perindopril is also indicated in some territories for use in managing stable coronary artery disease and certain types of heart failure.

Q: Does Prenewel cause changes in mood or sleep?

A: Official side effect lists document mood alterations, sleep disturbances, and insomnia as uncommon or rare effects associated with the active ingredients of the medicine.

Q: What medical tests are usually needed while taking Prenewel?

A: Official documentation advises that the usual medical follow-up includes monitoring of potassium levels and creatinine, which is a measure used to check kidney function.

Q: Is it possible to take too much Prenewel?

A: Yes, taking more than the prescribed dose is possible. The most likely symptom of overdose noted in regulatory documents is pronounced hypotension (very low blood pressure), which may be associated with dizziness or fainting.

Q: Are there long-term side effects associated with Prenewel use?

A: The official safety profile reports adverse reactions based on their frequency over the course of treatment. Documented effects that can occur long-term include cough and the potential risk of renal impairment (kidney damage) that requires continued monitoring.

Q: Are there any documented cases of Prenewel causing liver problems?

A: The official safety profile notes the risk of hepatic encephalopathy (liver-related brain dysfunction) in patients with severe pre-existing liver issues. Rare cases of hepatitis (liver inflammation) have also been reported with the active ingredients.

Q: What if I start getting muscle cramps after starting Prenewel?

A: Official adverse effect lists document muscle spasms and myalgia (muscle pain) as undesirable effects that have been reported with the active components of the medicine.

Q: What is the difference between Prenewel and Prenewel Forte?

A: Official drug registries indicate that 'Forte' versions of fixed-dose combination medicines typically contain higher strengths of one or both of the active ingredients compared to the standard version.

Q: Is Prenewel a commonly prescribed medication for hypertension?

A: Prenewel is one of the globally recognized trade names for the perindopril/indapamide combination, which is an established dual therapy used in the long-term treatment of essential hypertension.

Q: Why is Prenewel generally started at a low dose?

A: The product information states that the fixed-dose combination is not suitable for initial therapy and that individual components should be used for titration. Starting at a low dose is a standard practice for blood pressure medicines to minimize the risk of sudden hypotension (low blood pressure) and allow close monitoring.

Q: Are there known interactions between Prenewel and common cold/flu remedies?

A: Official documentation contains warnings for certain drug classes often found in cold/flu remedies. Specifically, the combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is noted for potentially reducing the blood pressure-lowering effect and increasing the risk of kidney function decline.

Q: How long does Prenewel stay in your system after stopping it?

A: Pharmacokinetic studies indicate that the half-life of the active components is approximately 14 to 17 hours. This value reflects the time it takes for half of the substance to be eliminated from the body.

How should Prenewel be stored and disposed of?

How to Store and Dispose of Prenewel: Official Regulatory Information

Storage and disposal requirements for Prenewel are defined by regulatory authorities to ensure product stability and safety. The official labeled instructions are as follows:


Storage Conditions

Requirement Official Instruction
Temperature Store below 30 C
Prohibited Environments Do not refrigerate or freeze
Protection Keep in the original package to protect from light and moisture
Safety Keep out of the sight and reach of children

Disposal Requirements

Official instructions mandate that Prenewel must not be disposed of via household waste or wastewater. To protect the environment, unused or expired medicine should be returned to a pharmacist for proper disposal. Always check the packaging and do not use the medicine after the stated expiry date.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prenewel found in:

A-Z Index: